Literature DB >> 10806175

Roles of ICAM-1 for abnormal leukocyte recruitment in the microcirculation of bleomycin-induced fibrotic lung injury.

N Sato1, Y Suzuki, K Nishio, K Suzuki, K Naoki, K Takeshita, H Kudo, N Miyao, H Tsumura, H Serizawa, M Suematsu, K Yamaguchi.   

Abstract

To assess the importance of endothelial intercellular adhesion molecule-1 (ICAM-1) in microvascular leukocyte kinetics in diseased lungs, we investigated the transitional changes in ICAM-1 expression, vascular diameter, and leukocyte behavior in rat pulmonary microcirculation during the development of acute lung injury (ALI) and chronic fibrosis (FIB) evoked by bleomycin (BLM). Observations were made in the isolated perfused lung with a real-time confocal laser luminescence microscope. Microvascular cell kinetics were evaluated by measuring the behavior of fluorescence- labeled leukocytes and erythrocytes in the presence or absence of anti-ICAM-1 monoclonal antibody (1A29). Arteriolar ICAM-1 showed little change at any time after BLM treatment. Venular ICAM-1 was first enhanced at the initial phase of ALI followed by the second upregulation at the early phase of FIB. Capillary ICAM-1 showed a sustained increase at both ALI and FIB. Arteriolar and venular diameters were not altered but capillary diameter decreased during ALI and early FIB stages. Although firm adherence of leukocytes to arteriolar and venular walls was not observed, rolling leukocytes were increased in venules both at the initial phase of ALI and at the early phase of FIB. The leukocyte rolling in venules correlated well with transitional changes in ICAM-1 and was inhibited by 1A29. Sustained entrapment of leukocytes in capillaries was attributed to changes in vascular diameter as well as augmented ICAM-1. In conclusion, ICAM-1 plays an important role in microvascular leukocyte recruitment in both ALI and FIB in the BLM-injured lung.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806175     DOI: 10.1164/ajrccm.161.5.9907104

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

2.  Pingyangmycin-regulated expressions of adhesion molecules in human venous malformation endothelial cells.

Authors:  Yulin Jia; Jun Jia; Yifang Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

3.  Decreased pulmonary inflammation after ethanol exposure and burn injury in intercellular adhesion molecule-1 knockout mice.

Authors:  Melanie D Bird; Michelle O Morgan; Luis Ramirez; Sherri Yong; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2010 Jul-Aug       Impact factor: 1.845

4.  Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury.

Authors:  Heather G Leach; Izabela Chrobak; Rong Han; Maria Trojanowska
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

5.  Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.

Authors:  Xi Wang; Zhe Cheng; Lingling Dai; Tianci Jiang; Liuqun Jia; Xiaogang Jing; Lin An; Huan Wang; Meng Liu
Journal:  Mol Cell Biol       Date:  2019-05-28       Impact factor: 4.272

6.  Localization of endothelin receptors in bleomycin-induced pulmonary fibrosis in the rat.

Authors:  Martina Wendel; Anna Petzold; Roland Koslowski; Michael Kasper; Antje Augstein; Lilla Knels; Jörg-Uwe Bleyl; Thea Koch
Journal:  Histochem Cell Biol       Date:  2004-10-05       Impact factor: 4.304

Review 7.  Pulmonary endothelium in acute lung injury: from basic science to the critically ill.

Authors:  S E Orfanos; I Mavrommati; I Korovesi; C Roussos
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

8.  Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity.

Authors:  W Matsuyama; M Kawabata; A Mizoguchi; F Iwami; J Wakimoto; M Osame
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.

Authors:  Xue Zhou; You-Jie Li; Shu-Yan Gao; Xiao-Zhi Wang; Ping-Yu Wang; Yun-Fei Yan; Shu-Yang Xie; Chang-Jun Lv
Journal:  J Cell Mol Med       Date:  2015-02-20       Impact factor: 5.310

10.  Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.

Authors:  Congjie Wang; Xiaodong Song; Youjie Li; Fang Han; Shuyan Gao; Xiaozhi Wang; Shuyang Xie; Changjun Lv
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.